Sage Rhino Capital LLC Abbott Laboratories Transaction History

Sage Rhino Capital LLC

$439 Million
Q3 2024

A detailed history of Sage Rhino Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sage Rhino Capital LLC holds 2,997 shares of ABT stock, worth $354,035. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,997

Previous 2,963 1.15%

Holding current value

$354,035

Previous $307,000 11.07%

% of portfolio

0.08%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$100.07 - $118.13 $3,402 - $4,016	34 Added 1.15%	2,997 $341,000
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $4,432 - $4,947	44 Added 1.51%	2,963 $307,000
Q1 2024 Apr 26, 2024	BUY	$109.52 - $120.96 $4,818 - $5,322	44 Added 1.53%	2,919 $331,000
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $2,886 - $3,532	-32 Reduced 1.1%	2,875 $316,000
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $5,063 - $6,074	-53 Reduced 1.79%	2,907 $281,000
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $3,023 - $3,368	30 Added 1.02%	2,960 $322,000
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $3,099 - $3,648	32 Added 1.1%	2,930 $296,000
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $190 - $223	2 Added 0.07%	2,898 $318,000
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $1,257 - $1,456	-13 Reduced 0.45%	2,896 $280,000
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $4,184 - $5,058	-41 Reduced 1.39%	2,909 $316,000
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $1,482 - $1,807	13 Added 0.44%	2,950 $349,000
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $5,314 - $6,507	46 Added 1.59%	2,937 $413,000
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $6,532 - $7,227	56 Added 1.98%	2,891 $342,000
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $4,337 - $5,105	41 Added 1.47%	2,835 $329,000
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $10,013 - $11,797	-92 Reduced 3.19%	2,794 $335,000
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $17,535 - $19,108	-167 Reduced 5.47%	2,886 $316,000
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $458 - $556	5 Added 0.16%	3,053 $332,000
Q2 2020 Jul 30, 2020	BUY	$76.57 - $98.0 $5,972 - $7,644	78 Added 2.63%	3,048 $279,000
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $3,015 - $4,409	48 Added 1.64%	2,970 $234,000
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $2,590 - $2,884	33 Added 1.14%	2,922 $249,000
Q3 2019 Oct 25, 2019	BUY	$81.84 - $88.74 $2,209 - $2,395	27 Added 0.94%	2,889 $242,000
Q1 2019 Apr 18, 2019	BUY	$66.22 - $80.06 $189,521 - $229,131	2,862 New	2,862 $229,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Abbott Laboratories Transaction History